BIOLATAM 2013 aims to become the global event focused on Latin American biotechnology. BIOLATAM 2013 is the perfect setting for forging new partnerships and strengthening existing business relationships in the Latin American biotechnological market.
BIOLATAM 2013 will combine conferences, business meetings and networking events, to facilitate contacts between international companies, investors, entrepreneurs, institutions and research centers in the field of biotechnology and related areas.
Cristina Garmendia (Spain), Former Spanish Minister of Science and Innovation / Hugo Villegas (USA), President for Latam Area, COVIDIEN / Gabriela Couto (Costa Rica), Expert in biotechnology industry / Carlos Moro (Spain), President of the Matarromera Group / Daniel Ramón (Spain), CEO of Biopolis / Consuelo Valverde (USA), Founder of ZFunction Fund / Al Costa (Brasil), General Manager of Alkol Bioenergy / Ángel Santos (Spain), Director of Business Development at CRB Inverbío / Neil Thomas (USA), Partner of Ventac Partners / Gianfranco Grompone (France), Senior Science Manager in Danone Research / Lorena Guevara (Costa Rica), Deputy Minister of Environment and Energy in Costa Rica / Alba Lucía Valenzuela (Colombia), Head of Efficacy & Safety in Vitro Laboratory of Belcorp / Juan Carlos Alvarez (Spain), Social Policies Department Adviser at the Spanish Government Presidency Cabinet / Pablo Ortiz (Spain), Market Strategy Manager at OWL / Javier Velasco (Spain), CEO of Neol Biosolutions / María Mercedes Zambrano (Colombia), Scientific Director in Corporación Corpogen / Laura Charry (USA), Business Development for South America at Magellan Bioscience Group / Marieta Marín-Buzos (Cuba), Specialist in Agrobiotechnology at CIGB, Cuban Center for Genetic Engineering and Biotechnology / Jorge Arenas-Vidal (Spain), CEO of BioSerentia Group / Willy A. Valdivia-Granda (USA), CEO of Orion Integrated Biosciences / Oscar Puig (USA), Biomarker & Experimental Medicine Leader at ROCHE, Translational Clinical Research Center / Aleck Santamaría de la Cruz (Colombia), General Manager of Bioenergy / Carlos Eduardo Calmanovici (Brasil), CEO of ANPEI (Associação Nacional de Pesquisa e Desenvolvimento das Empresas Innovadoras) / João Paulo Poiares Baptista (Brazil), Managing Director, Burrill Brasil Gestão De Recursos S.A. / Felipe Camposano (Chile), General Partner, Austral Capital & President, ASEMBIO - Chilean Association of Biotechnology Companies / Santiago de Torres, President (Spain), Inveready Biotech II SCR / Oriol Argemi (Spain), Responsible of Business Development, Grifols Engineering S.A. / Erick Sabido Ruiz (Mexico), Biotechnology Division Manager, Sartorius de México S.A. / Carlos Eduardo Calmanovici (Brazil), President, Anpei (Associação Nacional de Pesquisa e Desenvolvimento das Empresas Innovadoras) / Roberto Horcajada (Spain), Project Dept. Sub-Director & International Projects Manager, Inkemia Iuct Group S.A / Bernardo Camacho (Colombia), Scientific Director, Distrital Health Secretariat of Bogotá / José Terencio (Spain), COO, Gri-Cel / Alexander Grobman (Peru), President, Ethano Peru LLC / Juan Carlos Briceño (Colombia), Dean, Biomedical Engineering Faculty of Los Andes University / Jaime Mauricio Concha (Colombia), Managing Director, Andi (National Business Association of Colombia) / Oscar Expósito (Spain), CSO, Phyture Biotech S.L. / Joseph Fernández (USA), CEO, Active Motif / Rocio Sierra-Honigmann (USA), CEO, Amerstem Inc / Julio Castro (Spain), CEO, Palo Biofarma S.L. / Bernadette Klotz (Colombia), General Manager, Alpina Corporatico / Olga Genilloud (Spain), Scientific Director, Fundación Medina / Jorge Huete-Pérez (Nicaragua), President, Nicaraguan Academy of Sciences / Pedro Bustamante–Gallardo (Chile), IBPG LTDA / Alfredo Sánchez (Colombia), Sales Manager, Vecol S.A. / Manolo Fernández (Peru), Manager, Farvet S.A.C. / Jorge Granados (Colombia), President, Asobiotec (Colombian Biotechnology Association) / Vanessa Silva da Silva (Brazil), Executive Coordinator, Ambiotec (Associação Mineira de Empresas de Biotecnologia e Ciéncias da Vida) / Antonio Vila-Coro (Spain), Head of Business Development, Vivotecnia Research S.L. /